| 2024年年报 | 2023年年报 | |
|---|---|---|
| 营业收入(元) | ||
| CDMO(元) | 7,192,017.27 | 13,318,407.95 |
| 锂电池电解液添加剂(元) | 252,645,357.43 | 275,091,063.96 |
| 医药制造业(元) | 918,009,227.95 | 1,321,260,516.44 |
| 营业成本(元) | ||
| CDMO(元) | 3,708,648.49 | 7,389,679.55 |
| 锂电池电解液添加剂(元) | 273,835,719.49 | 294,225,409.50 |
| 医药制造业(元) | 786,459,828.23 | 1,137,002,225.49 |
| 毛利(元) | ||
| CDMO(元) | 3,483,368.78 | 5,928,728.40 |
| 锂电池电解液添加剂(元) | -21,190,362.06 | -19,134,345.54 |
| 医药制造业(元) | 131,549,399.72 | 184,258,290.95 |
| 毛利率(%) | ||
| CDMO(%) | 48.43 | 44.52 |
| 锂电池电解液添加剂(%) | -8.39 | -6.96 |
| 医药制造业(%) | 14.33 | 13.95 |
| 收入构成(%) | ||
| CDMO(%) | 0.61 | 0.83 |
| 锂电池电解液添加剂(%) | 21.45 | 17.09 |
| 医药制造业(%) | 77.94 | 82.08 |
| 毛利构成(%) | ||
| CDMO(%) | 3.06 | 3.47 |
| 锂电池电解液添加剂(%) | -18.61 | -11.19 |
| 医药制造业(%) | 115.55 | 107.72 |